4.7 Article

Reactive Centre Loop Mutagenesis of SerpinB3 to Target TMPRSS2 and Furin: Inhibition of SARS-CoV-2 Cell Entry and Replication

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Immunology

Proteolytic activation of SARS-CoV-2 spike protein

Makoto Takeda

Summary: This review discusses the crucial role of S protein cleavage in coronavirus infection, particularly focusing on SARS-CoV-2. The complexity of the cleavage activation mechanism of the S protein is highlighted, with different cleavage sites and motifs involved. Variants of concern with enhanced infectivity have emerged during the ongoing pandemic, demonstrating the significant impact of changes in S protein cleavability on viral infectivity and virulence.

MICROBIOLOGY AND IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation

Akatsuki Saito et al.

Summary: During the COVID-19 pandemic, the B.1.617.2/Delta variant has been found to be highly fusogenic and more pathogenic in infected hamsters compared to prototypic SARS-CoV-2. The P681R mutation in the spike protein of this variant enhances viral fusogenicity and pathogenicity.

NATURE (2022)

Article Multidisciplinary Sciences

A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic

Tirosh Shapira et al.

Summary: The COVID-19 pandemic caused by the SARS-CoV-2 virus is still a global public health crisis, with reduced efficacy of vaccination campaigns due to emerging variants of concern. Development of host-directed therapeutics and prophylactics can limit resistance and provide urgently needed protection against these variants.

NATURE (2022)

Article Cell Biology

Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant

Yang Liu et al.

Summary: This study reports that the P681R mutation in the Delta spike plays a crucial role in the replacement of the Alpha variant by the Delta variant during the COVID-19 pandemic. The Delta variant outcompetes the Alpha variant in human lung cells and airway tissues. The P681R mutation enhances the cleavage of the spike protein, leading to increased replication of the Delta variant.

CELL REPORTS (2022)

Article Biochemistry & Molecular Biology

Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation

Bryan J. Fraser et al.

Summary: This study provides insights into the structure and function of TMPRSS2, a key protein involved in the viral entry and pathogenesis of SARS-CoV-2. By studying its structure and cleavage sites, the researchers also uncovered the specificity of TMPRSS2, which can aid in drug development efforts.

NATURE CHEMICAL BIOLOGY (2022)

Article Microbiology

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

Brian J. Willett et al.

Summary: Vaccines based on the spike protein of SARS-CoV-2 are vital in combating COVID-19, but the emergence of the Omicron variant poses a threat to this strategy. Studies have shown that the Omicron variant evades neutralization by sera from individuals vaccinated with different vaccines and reduces real-world vaccine effectiveness, although booster vaccination can partially restore its effectiveness. Additionally, the Omicron variant exhibits distinct cell entry pathways and phenotypes, which may contribute to its rapid global spread and altered pathogenicity.

NATURE MICROBIOLOGY (2022)

Article Cell Biology

Novel cleavage sites identified in SARS-CoV-2 spike protein reveal mechanism for cathepsin L-facilitated viral infection and treatment strategies

Miao-Miao Zhao et al.

Summary: This study identifies two previously unidentified Cathepsin L (CTSL) cleavage sites in the spike protein of SARS-CoV-2. CTSL cleavage promotes the adoption of a specific conformation by the spike protein, facilitating receptor binding and membrane fusion. Inhibitors targeting CTSL not only block viral infection in cells, but also reduce live virus infection in lung tissues. CTSL-specific inhibitors show promising effects in preventing live virus infection in animal models. Inhibition of CTSL cleavage could be a potential strategy for developing mutation-resistant therapies.

CELL DISCOVERY (2022)

Article Biotechnology & Applied Microbiology

Distinct Molecular Mechanisms Characterizing Pathogenesis of SARS-CoV-2

Su Jin Lee et al.

Summary: Understanding the molecular mechanisms of SARS-CoV-2 propagation and pathogenesis is crucial for the development of effective vaccines and therapeutics. Recent research has provided significant insights into these aspects.

JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2022)

Article Multidisciplinary Sciences

Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis

Bryan A. Johnson et al.

Summary: The genetic mutation in SARS-CoV-2 resulted in better fitness in some cells but lower replication capacity in human respiratory cell lines. Despite reducing disease symptoms, the Delta PRRA mutant provided protection against rechallenge with the wildtype SARS-CoV-2.

NATURE (2021)

Article Microbiology

Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion

Guido Papa et al.

Summary: Research suggests that furin plays a promoting role in SARS-CoV-2 infectivity and cell-cell spread, but it is not essential, indicating that furin inhibitors may reduce but not completely prevent viral spread.

PLOS PATHOGENS (2021)

Letter Medicine, General & Internal

Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2

Saman Saadat et al.

Summary: This study compared the titers of binding and neutralizing antibodies in healthcare workers previously infected with SARS-CoV-2 after receiving a single dose of mRNA coronavirus vaccine.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Multidisciplinary Sciences

A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells

Matthew Mahoney et al.

Summary: A novel TMPRSS2 inhibitor, MM3122, has shown exceptional potency in inhibiting viral entry and reducing cytopathic effects, with promising potential as a treatment for COVID-19. This compound, discovered using SBDD, exhibits unique structural features and excellent pharmacokinetic properties, making it a strong candidate for in vivo efficacy evaluation.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Biochemistry & Molecular Biology

A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research

Suzannah J. Rihn et al.

Summary: The report introduces a range of tools for SARS-CoV-2 research, including a single plasmid reverse genetics system, a panel of antibodies, clinical isolates, and permissive cell lines. These tools have the potential to advance COVID-19 vaccine design, drug testing, and discovery science.

PLOS BIOLOGY (2021)

Article Immunology

IL1β Promotes TMPRSS2 Expression and SARS-CoV-2 Cell Entry Through the p38 MAPK-GATA2 Axis

Chiara Cioccarelli et al.

Summary: The study found that the host's inflammatory environment affects the susceptibility of SARS-CoV-2 infection by increasing TMPRSS2 expression, revealing the related molecular mechanisms.

FRONTIERS IN IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection

Lukas Wettstein et al.

Summary: This study identifies alpha (1)-antitrypsin (alpha (1)AT) as an inhibitor of SARS-CoV-2 entry by binding and inactivating the serine protease TMPRSS2, which primes the virus spike protein for membrane fusion. Alpha (1)AT suppresses viral replication and may have therapeutic potential for COVID-19 treatment.

NATURE COMMUNICATIONS (2021)

Review Cardiac & Cardiovascular Systems

Therapeutic SERPINs: Improving on Nature

Coen Maas et al.

Summary: Serine proteases are controlled by serine protease inhibitors (SERPINs), with deficiency in SERPINs potentially leading to disease. Various strategies, including concentrates from plasma and recombinant SERPINs, can be used to treat SERPIN deficiencies. Rational design can reform and optimize the inhibitory properties of SERPINs.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Biochemistry & Molecular Biology

Computational analysis of TMPRSS2 expression in normal and SARS-CoV-2-infected human tissues

Wenxiu Cao et al.

Summary: TMPRSS2 is highly expressed in various human tissues and shows significant differences in SARS-CoV-2-infected patients, but not between different genders or age groups. The upregulated pathways are mainly involved in immune response, metabolism, cell growth, proliferation, and cancer.

CHEMICO-BIOLOGICAL INTERACTIONS (2021)

Article Biochemistry & Molecular Biology

TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells

Jana Koch et al.

Summary: SARS-CoV-2 infects cells through two mutually exclusive pathways depending on the presence of TMPRSS2 protease. In the presence of TMPRSS2, the virus swiftly enters through the plasma membrane in a pH-independent manner; while in the absence of TMPRSS2, the virus is endocytosed and enters the cytosol post-infection.

EMBO JOURNAL (2021)

Review Biochemistry & Molecular Biology

Engineering the serpin α1-antitrypsin: A diversity of goals and techniques

Benjamin M. Scott et al.

PROTEIN SCIENCE (2020)

Article Multidisciplinary Sciences

Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

Shutoku Matsuyama et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Biochemistry & Molecular Biology

A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

Markus Hoffmann et al.

MOLECULAR CELL (2020)

Review Pharmacology & Pharmacy

Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients

Tianxiao Liu et al.

PHARMACOLOGY & THERAPEUTICS (2020)

Editorial Material Oncology

The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer

Veronica Mollica et al.

FUTURE ONCOLOGY (2020)

Article Multidisciplinary Sciences

Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site

Javier A. Jaimes et al.

ISCIENCE (2020)

Article Biochemistry & Molecular Biology

The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins

Carina Conceicao et al.

PLOS BIOLOGY (2020)

Review Medicine, General & Internal

SERPINs-From Trap to Treatment

Wariya Sanrattana et al.

FRONTIERS IN MEDICINE (2019)

Article Multidisciplinary Sciences

Reactive centre loop dynamics and serpin specificity

Emilia M. Marijanovic et al.

SCIENTIFIC REPORTS (2019)

Review Biochemistry & Molecular Biology

The role of type II transmembrane serine protease-mediated signaling in cancer

Lauren M. Tanabe et al.

FEBS JOURNAL (2017)

Review Biochemistry & Molecular Biology

TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections

Li Wen Shen et al.

BIOCHIMIE (2017)

Review Hematology

Targeting activated protein C to treat hemophilia

Stephanie G. I. Polderdijk et al.

CURRENT OPINION IN HEMATOLOGY (2017)

Article Biochemistry & Molecular Biology

Design and characterization of a novel human Granzyme B inhibitor

Marcelo Marcet-Palacios et al.

PROTEIN ENGINEERING DESIGN & SELECTION (2015)

Article Developmental Biology

Evolutionary crossroads in developmental biology: cyclostomes (lamprey and hagfish)

Sebastian M. Shimeld et al.

DEVELOPMENT (2012)

Review Cardiac & Cardiovascular Systems

The discovery of α1-antitrypsin and its rote in health and disease

Sabina M. Janciauskiene et al.

RESPIRATORY MEDICINE (2011)

Article Biochemistry & Molecular Biology

Heparin Enhances Serpin Inhibition of the Cysteine Protease Cathepsin L

Wayne J. Higgins et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Multidisciplinary Sciences

Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites

Sandrine Belouzard et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Biochemistry & Molecular Biology

Phenotypic analysis of mice lacking the Tmprss2-encoded protease

TS Kim et al.

MOLECULAR AND CELLULAR BIOLOGY (2006)

Article Medicine, General & Internal

A pilot study comparing the purity, functionality and isoform composition of alpha-1-proteinase inhibitor (human) products

DI Cowden et al.

CURRENT MEDICAL RESEARCH AND OPINION (2005)

Article Biochemistry & Molecular Biology

Serpin polymerization is prevented by a hydrogen bond network that is centered on His-334 and stabilized by glycerol

AW Zhou et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

Article Biochemistry & Molecular Biology

α1-proteinase inhibitor mutants with specificity for plasma kallikrein and Cls but not Cl

T Sulikowski et al.

PROTEIN SCIENCE (2002)

Review Cell Biology

Furin at the cutting edge: From protein traffic to embryogenesis and disease

G Thomas

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)